Department of Industrial and Molecular Pharmaceutics, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA; Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
Department of Industrial and Molecular Pharmaceutics, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.
Adv Drug Deliv Rev. 2024 Oct;213:115445. doi: 10.1016/j.addr.2024.115445. Epub 2024 Aug 31.
Deformability is one of the critical attributes of nanoparticle (NP) drug carriers, along with size, shape, and surface properties. It affects various aspects of NP biotransport, ranging from circulation and biodistribution to interactions with biological barriers and target cells. Recent studies report additional roles of NP deformability in biotransport processes, including protein corona formation, intracellular trafficking, and organelle distribution. This review focuses on the literature published in the past five years to update our understanding of NP deformability and its effect on NP biotransport. We introduce different methods of modulating and evaluating NP deformability and showcase recent studies that compare a series of NPs in their performance in biotransport events at all levels, highlighting the consensus and disagreement of the findings. It concludes with a perspective on the intricacy of systematic investigation of NP deformability and future opportunities to advance its control toward optimal drug delivery.
变形性是纳米颗粒(NP)药物载体的关键属性之一,与尺寸、形状和表面特性并列。它影响 NP 生物转运的各个方面,从循环和生物分布到与生物屏障和靶细胞的相互作用。最近的研究报告称,NP 变形性在生物转运过程中还具有其他作用,包括蛋白质冠形成、细胞内转运和细胞器分布。本综述重点介绍了过去五年发表的文献,以更新我们对 NP 变形性及其对 NP 生物转运影响的理解。我们介绍了调节和评估 NP 变形性的不同方法,并展示了最近的研究,这些研究比较了一系列 NP 在各个水平的生物转运事件中的性能,突出了研究结果的一致性和分歧。最后,我们对系统研究 NP 变形性的复杂性以及未来控制其以实现最佳药物递送的机会进行了展望。